Richard J. DePiano passed away on Oct. 3, 2019. He was a member of the University’s Board of Trustees
, joining in 2003, and served on the University’s Finance and Institutional Advancement committees during his tenure.
“Rich was a mentor and friend who brought a great deal of financial expertise and experience to our board,” said Salus president Michael H. Mittelman, OD, MPH, MBA, FAAO, FACHE. “He will be sorely missed.”
DePiano started his career in public accounting with Touche Ross (now Deloitte) in 1966, in which he became a partner in 1974 and then director of tax operations in the Philadelphia office. His area of concentration was federal taxation with an emphasis on healthcare, business organizations and acquisitions. After leaving Touche Ross, he spent a decade in venture capital as the CEO of the Sandhurst Company, L.P., and as managing director of the Sandhurst Venture Fund from 1986 to 1997.
DePiano then led Escalon Medical Corp., which develops, manufactures and distributes surgical and diagnostic products for ophthalmic applications, as CEO from 1997 until 2013 and was chairman of its Board of Directors. He also served on the board of LaFrace Corporation and as a trustee for Drexel University. He earned a Bachelor of Science degree in accounting from Drexel University and was a member of both the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants.